Novartis

Advertisement

WHO trial to study potential of 3 anti-malarial drugs against COVID-19

Novartis

Novartis to buy US gene therapy group AveXis for $8.7 billion

Novartis to buy US gene therapy group AveXis for $8.7 billion

GSK buys Novartis stake in consumer healthcare venture for $13 billion

GSK buys Novartis stake in consumer healthcare venture for $13 billion

US approves first gene therapy for cancer

US approves first gene therapy for cancer

Sun Pharma to acquire oncology product from Novartis for $175 million

Sun Pharma to acquire oncology product from Novartis for $175 million

Sniff your way to `slimmer` you with `love hormone` spray

Sniff your way to `slimmer` you with `love hormone` spray

NeoBiocon to sell anti-diabetic drug in UAE

NeoBiocon to sell anti-diabetic drug in UAE

Antim Baazi: NeoBiocon Partners with Novartis

Antim Baazi: NeoBiocon Partners with Novartis

US fines Novartis $390 million over pharmacy kickbacks

US fines Novartis $390 million over pharmacy kickbacks

Novartis India gets FIPB nod to sell OTC biz to GSK CPL

Novartis India gets FIPB nod to sell OTC biz to GSK CPL

New-look GSK bets on consumer health spending

New-look GSK bets on consumer health spending

Novartis warns of currency drag on 2015 earnings

Novartis warns of currency drag on 2015 earnings

GSK Pharma to transfer cancer drug portfolio to Novartis arm

GSK Pharma to transfer cancer drug portfolio to Novartis arm

Novartis Q3 net loss at Rs 1.18 crore

Novartis Q3 net loss at Rs 1.18 crore

EU puts conditions on deals involving Novartis, GSK

EU puts conditions on deals involving Novartis, GSK

Novartis profits jump 12% on new drug sales

Novartis profits jump 12% on new drug sales

HC order 'disappointing', says Cipla

HC order 'disappointing', says Cipla

Novartis shares up nearly 2% at close

Novartis shares up nearly 2% at close

CCI clears multi-billion Novartis-GSK pharma deal

CCI clears multi-billion Novartis-GSK pharma deal

HC reserves order on Novartis-Cipla drug dispute

HC reserves order on Novartis-Cipla drug dispute

Load More Stories